GYNE-LOTRIMIN 3 (clotrimazole) by Bayer is clinical pharmacology clotrimazole is a broad-spectrum antifungal agent that is used for the treatment of dermal infections caused by various species of pathogenic dermatophytes, yeasts, and malassezia furfur . First approved in 1998.
Drug data last refreshed 5h ago · AI intelligence enriched 1mo ago
GYNE-LOTRIMIN 3 is a broad-spectrum antifungal cream containing clotrimazole, indicated for vaginal yeast infections caused by Candida species and other fungal pathogens. The drug works by disrupting fungal cell membranes, causing leakage of intracellular components and inhibiting both dividing and growing organisms. Clotrimazole exhibits both fungistatic and fungicidal activity with minimal systemic absorption when applied topically or vaginally.
Product approaching loss of exclusivity with moderate competitive pressure (30), signaling transition from growth-stage team to legacy/maintenance operations.
CLINICAL PHARMACOLOGY Clotrimazole is a broad-spectrum antifungal agent that is used for the treatment of dermal infections caused by various species of pathogenic dermatophytes, yeasts, and Malassezia furfur . The primary action of clotrimzole is against dividing and growing organisms. In vitro ,…
Worked on GYNE-LOTRIMIN 3 at Bayer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor
Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%)
Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis
Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.
Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis
Working on GYNE-LOTRIMIN 3 offers limited career growth opportunity given its LOE-approaching status and mature market position. Roles focus on protecting market share, managing generic transition, and optimizing commercial efficiency rather than launching or expanding market opportunities.